Study Examines Risk for ONJ in Cancer Patients Who Take Bone-Modifying Agents

An investigation by researchers at the University of Michigan Comprehensive Cancer Center in Ann Arbor examined the association between osteonecrosis of the jaw (ONJ) in cancer patients and the use of bone-modifying agents to reduce the risk for skeletal events associated with bone metastases from cancer treatment.

One study was a prospective observational analysis of nearly 3,500 cancer patients who had metastatic bone disease and were treated with bone-modifying agents, including zoledronic acid. Findings show that after three years, the cumulative incidence of ONJ in all cancer patients was 2.8%. The risk was highest for patients who wore dentures, who had undergone dental surgery, and current smokers.

The full studies are available at: clinicaltrials.gov/ct2/show/NCT00874211 And clinicaltrials.gov/ct2/show/NCT00127205

 

Add a Comment

Your email address will not be published. Required fields are marked *

OSAP Announces Winners of Infection Control Leadership Awards

The Organization for Safety, Asepsis and Prevention (OSAP) has announced the...

Dental professional with child
NYU Dentistry/Henry Schein Cares Global Student Outreach Program Provided Free Oral Health care to 3,000+ People During 2018-2019 School Year

More than 3,000 people in four different countries – 2,049 children...

A-DEC ACQUIRES DEAN DENTAL SYSTEMS

Newberg-based A-dec Inc has announced it has acquired the assets of...

UB Program Introduces Native American Students to Careers in Dentistry

The University at Buffalo School of Dental Medicine and Seneca Nation...

Study Shows SmartMouth Clinical DDS Effective Alternative to Prescription Chlorhexidine

SmartMouth Oral Health Laboratories’ Clinical DDS Advanced Oral Rinse is featured...

Freedom Assistant Cart

ASI’s new Freedom Dental Delivery System elevates an esthetic design preference...

INBRACE
INBRACE Smartwires

INBRACE’s Smartwire system features a design tailored to each
 patient’s unique...

A-dec 500
A-dec Introduces the New A-dec 500

Focused on creating a superior doctor and patient experience, the new...